There is an ongoing clinical trial to investigate the effectiveness of adjuvant endocrine therapy for operable ERβ positive, ERα/PR negative, HER-2 negative breast cancer (https://clinicaltrials.gov/ct2/show/NCT02089854). The gene discussed is ESR2; the disease is breast cancer.